Furthermore, a clear decrease in CX3CL1 concentration was also found when control and AD dementia samples were compared (C = 0.31 ± 0.05 ng/ml vs. AD = 0.166 ± 0.05 ng/ml; ∗∗∗p < 0.0001). Here, CX3CL1 is linked to Alzheimer disease.